According to Catalyst Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 1,05ย โฌ. In 2022 the company made an earnings per share (EPS) of 0,76ย โฌ an increase over its 2021 EPS that were of 0,36ย โฌ.